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Background: The site of Jagged/Serrate ligand recognition by Notch is unknown.
Results: Two critical residues involved in an intramolecular hydrophobic interaction across the central -sheet of EGF12 form
a ligand-binding platform.
Conclusion: The ligand-binding region is adjacent to a Fringe-sensitive residue involved in modulating Notch activity.
Significance: The results have implications for understanding receptor/ligand recognition, Notch regulation by O-glycosyla-
tion, and the development of paralogue-specific antibodies.
Wehavemapped a Jagged/Serrate-binding site to specific res-
idues within the 12th EGF domain of human and Drosophila
Notch. Two critical residues, involved in a hydrophobic interac-
tion, provide a ligand-binding platform and are adjacent to a
Fringe-sensitive residue thatmodulatesNotch activity.Ourdata
suggest that small variations within the binding site fine-tune
ligand specificity,whichmay explain theobserved sequencehet-
erogeneity in mammalian Notch paralogues, and should allow
the development of paralogue-specific ligand-blocking antibod-
ies.As a proof of principle,wehave generated aNotch-1-specific
monoclonal antibody that blocks binding, thus paving the way
for antibody tools for research and therapeutic applications.
The Notch receptor mediates a critical short range signal
that is deployed in many developmental and adult contexts to
refine cell fate choices (1). Genetic diseases affecting Notch
pathway components give rise to awide range of congenital and
adult-onset disorders, andNotch dysregulation has been found
to contribute to many types of human cancer (2). The Notch
receptor is a single pass trans-membrane protein that, during
its biosynthetic pathway, may be cleaved by a furin-like conver-
tase (S1) in the trans-Golgi to generate a noncovalently associ-
ated heterodimer at the cell surface (3, 4). Canonical Notch
signaling is initiated when a cell surface-expressed Delta/
Serrate/LAG-2 (DSL)3 ligand binds in trans to theNotch recep-
tor expressed on an opposing cell surface (5). Various studies
have localized the binding determinants to EGF11–12 of the
receptor and the DSL and EGF1–2 of the ligands (6, 7). Endocy-
tosis of the Notch ligand complex by the ligand-expressing cell
leads to a second proteolytic cleavage event at S2, which
removes the extracellular moiety of the heterodimer (8). This
leaves the membrane-tethered stalk, which is then cleaved by
-secretase at S3 (see Fig. 1a) (9, 10). Following this proteolysis
event, an intracellular fragment of Notch is released (11, 12).
This translocates to the nucleus and assembles into a transcrip-
tional activation complex, which includes a DNA-binding pro-
tein of the CBF-1/Suppressor of Hairless/LAG-1 (CSL) family
and its co-activator Mastermind. This new assembly relieves
repression and activates Notch target genes such as Hairy/En-
hancer of split (Hes) (13).
We have previously shown that the 12th EGF (EGF12)
domain of Notch is directly implicated in ligand binding (14),
To investigate this region further, we have made a series of
single amino acid substitutions in human and Drosophila
Notch designed to probe ligand recognition, while retaining
Notch calciumbinding,which is already known to be critical for
this interaction (15).Using flow cytometry and cell aggregation
assays, we have identified a globally conserved hydrophobic
binding site that is adjacent to the residue that forms part of the
O-fucosylation consensus sequence (C2-X4-(S/T)-C3) in EGF12,
where C2 and C3 represent the second and third conserved
cysteines (16). This residue is reported to be subjected to fur-
ther modification by the Fringe enzymes (17), resulting in
changes to Notch activity (18). We discuss the functional sig-
nificance of sequence variability within this region and show
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that it can be exploited to raise paralogue-specific antibodies
that block ligand binding.
EXPERIMENTAL PROCEDURES
Protein Production—hN-111–13 was bacterially expressed
and refolded in vitro as described previously and contains a 17-
amino acid biotin ligase (BirA) tag at theC terminus, whichwas
shown to increase the efficiency of refolding (19). Calcium
binding by hN-111–13 wild type and mutants was measured by
one-dimensional and two-dimensional NOE NMR spectros-
copy, as described previously (20, 21).
Flow Cytometry of J-1/N-1 Interaction—Prokaryotically
expressed and biotinylated hN-111–13 wild-type and mutant
constructs were coupled to purple fluorescent avidin-coated
beads (Spherotech), as described previously (14). A negative
control of calcium-binding EGF12–14 fromhuman fibrillin-1, an
unrelated protein with a similar domain organization, was used
in all experiments. Coupled beads were washed with 100 l of
HBSS/BSA (Hanks’ buffered saline solution without phenol
red, 1% BSA), resuspended in 50 l of HBSS, 10% fetal calf
serum (FCS) and kept on ice before being incubated with the
cells. Stably transfected B16 mouse melanoma cells expressing
full-length mouse Jagged-1 (J-1) were grown in T75 flasks to
80–90% confluency before being detached with 5ml of PBS, 10
mMEDTA at 37 °C for 5min. Pelleted cells from each flaskwere
washed three times and resuspended in 1 ml of ice-cold HBSS,
10% FCS. After 1 h, 50 l of the beads were added to 50 l of
cells and incubated on ice for 1 h prior to being resuspended in
500 l of ice-cold HBSS for flow cytometry analysis. hN-1-
binding antibodies (see below) were screened for their ability to
block binding of hN-111–13 to HEK293 cells expressing full-
length human J-1 by the addition of 10 l of hybridoma super-
natant to the coupled beads prior to incubation with cells. Flow
cytometry was performed using a FACSCalibur machine (BD
Biosciences). 10,000 cells were counted, and fluorescence
intensity was monitored in FL3 at670 nm, with excitation at
488 nm.
Drosophila Cell Aggregation Assay—For Serrate expression,
the 4.2-kb cDNA sequence from pBKSSerFL (22) was ampli-
fied by PCR to eliminate the stop codon, fused in-frame to a
V5-His tag at its C terminus, and inserted into the pMT expres-
sion vector (23) to generate pMT Ser-V5. Schneider S2 cells
(Invitrogen) were transfected with pMT-Ser-V5 as described
previously (15). Expression was induced with 1 mM CuSO4 at
48 h after transfection. After a further 16 h, cells were mixed
with Notch-expressing cells. For Notch expression, S2 cells
were transfected with pCaSper-HS Notch (19). Expression was
induced after 48 h by heat shock at 37 °C for 40 min and, after a
further 4 h at 25 °C, theyweremixedwithwild-type Ser-V5 cells
in 1.5-ml Eppendorf tubes on a rotating platform at room tem-
perature for 30min. The cell suspensionwas then transferred to
coverslips coated in 0.1% poly-L-Lysine (Sigma), fixed with 2%
formaldehyde, PBS for 40 min, and permeabilized with 0.2%
TritonX-100, PBS for 15min. Cells were blocked for 1 h in 0.2%
Triton X-100, PBS, 5% skimmed milk powder (Sigma-Aldrich)
and immunostained for 90minwith rabbit anti-V5 (Bethyl Lab-
oratories, 1:1000) and anti-Notch C17.9C6 (Developmental
StudiesHybridomaBank, IowaCity, IA, 1:500). Secondary anti-
bodies were -mouse-FITC (Jackson ImmunoResearch Labo-
ratories, 1:100) and -rabbit Cy3 (Jackson ImmunoResearch
Laboratories, 1:150). Slideswere imaged at63with aZeissM2
fluorescence microscope and cooled digital camera (Orca-ER
Hamamatsu), and processed using Openlab (Improvision) and
Photoshop (Adobe) on an Apple Macintosh computer. Images
displayedwere obtained by deconvolution using the three near-
est neighbors fromoptical sections obtainedwith a Z spacing of
0.5 m. Aggregation was scored for the percentage of Notch-
expressing cells adhering to at least one Serrate-expressing cell,
and the mean percentage of aggregation was obtained from at
least three independent transfections. Statistical significance
was assessed using Student’s t test.
Drosophila Notch Signaling—Full-length Drosophila Notch
(dN) and L504A constructs were subcloned into pMT vectors
(Invitrogen). S2 cells in 12-well dishes were transfected with
pMT plasmids, Notch Response Element (NRE):Firefly (gift
from S. Bray), and actin:Renilla (gift from G. Merdes). After
24 h, cells were resuspended and seeded into white 96-well
plates (Nunc 136101), andCuSO4was added after a further 24 h
to induce expression. Cells were reseeded into white 96-well
plates on top of fixed Delta-expressing S2 cells (S2-Mt-Dl;Dro-
sophilaGenomics Resource Center (DGRC)). 24 h after induc-
tion, luciferase activity was assayed with Dual-Glo Lucifer-
ase (Promega) and quantified by luminometer (Berthold
Technologies), and the Firefly/Renilla ratio was calculated
for triplicate samples. Experiments were repeated a mini-
mum of three times.
mAb Generation and Validation—Mouse monoclonal anti-
bodies (N1-96A, isotype IgG2a andN1-39E, isotype IgG1) were
raised, usingMF1mice andNS0 cells as the fusion partner (24).
The antigen was bacterially expressed recombinant hN-111–13
as described above, using TiterMax Gold as adjuvant. Fifteen
hybridoma cell lines, generated from three fusions, were posi-
tive for antibody reactivity against hN-111–13 by ELISA assay
against the immunogen. Two hybridoma lines (N1-39E and
N1-96A) were found to be positive for the detection of cell
surface N-1 by FACS analysis of transient HEK293T transfec-
tants. For epitope mapping, wild-type and mutant hN-111–13
constructs were prepared at 20 ng/l, and 1 l of each was
spotted onto nitrocellulose. The proteins were detected with
the noninhibitory antibody N1-96A (1:200) and the blocking
antibody N1-39E (1:400) followed by anti-mouse HRP conju-
gate (1:2000) and visualized by chemiluminescence (Amer-
sham Biosciences ECL Plus Western blotting detection
system).
Flow Cytometry and Immunocytochemistry to Test Paralogue
Specificity—Full-length human Notch-1, -2, -3, and -4 tran-
siently transfected HEK293T cells were generated. Cells were
washed three times with FACSWash Buffer (2% FBS in PBS
0.01%NaN3) and then incubated on ice for 20minwith primary
antibody, i.e. undiluted hybridoma supernatant. After two
washeswith FACSWashBuffer, cellswere incubated for 20min
at 4 °C (protected from light) with secondary conjugated anti-
body, i.e. allophycocyanin-conjugated anti-mouse Ig (HL)
(Invitrogen, A10539) at 1:50 dilution. Cells were washed with
FACSWash Buffer and resuspended in 500 l of 1% formalde-
hyde in PBS before analysis using a FACSCalibur flow cytome-
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ter (BD Biosciences) and FlowJo software (Tree Star). Cytospin
cell preparations were incubated with primary antibody for
30 min at room temperature, Notch-1 (A6 mAb, Abcam, dilu-
tion 1:200), Notch-2 (goat polyclonal antibody, Abcam, dilu-
tion 1:200), Notch-3 (rabbit polyclonal antibody, Abcam,
dilution 1:200), Notch-4 (rabbit polyclonal antibody, Abcam,
dilution 1:200), or undiluted hybridoma supernatants. After
washing in PBS, slideswere incubatedwith secondary antibody,
HRP-conjugated goat-anti-mouse antibody (Dako, 1:50 dilu-
tion), for murine monoclonal antibodies (mAbs) or with HRP-
conjugated goat-anti-rabbit antibody for rabbit polyclonal anti-
bodies (Dako, 1:12.5 dilution) for 30 min at room temperature.
Goat antibodies were detected using a mouse-anti-goat mono-
clonal antibody between primary and secondary antibodies at a
1:12.5 dilution. After washing, color reaction was developed
using diaminobenzidine substrate (Dako). Slides were washed
and counterstained in hematoxylin before mounting in Aqua-
tex mounting agent (BDH/VWR International).
RESULTS ANDDISCUSSION
Site-directedMutagenesis of HumanN-111–13—Mutations in
hN-1 were made in the context of the soluble hN-111–13 con-
struct (Fig. 1a), which we have previously demonstrated to be
ligand binding-competent (19). To assay these hN-111–13
mutants, we have used flow cytometry to study binding to full-
length J-1 expressed on the surface of B16 cells. Initially, two
mutants containing alanine substitutions were constructed on
the basis of sequence conservation across Notch frommultiple
species (Fig. 1b). Of these, one was similar to wild type (WT) in
its ability to bind J-1 (M479A), but the other, L468A, was com-
pletely unable to bind J-1 (Fig. 2). Mapping Leu-468 to the
structure of hN-111–13 shows that it lies within the central
-hairpin of EGF12. TheNotch-binding region previously iden-
tified in the J-1 DSL domain makes it unlikely that Leu-468 is
the only residue to contribute to the ligand-binding interface
(19); we thereforemade a second round of alanine substitutions
at residues that were seen to lie close to this region and to have
surface-exposed side chains not involved in calcium coordina-
tion (Fig. 1b). This allowed us to identify one further mutant,
I477A, which abrogated binding similarly to L468A, two other
mutants, E473A and Q475A, which showed a more modest
reduction in binding, and one mutant, Q470A ,which bound at
least as well as WT hN-111–13 (Fig. 2a). Loss of binding to
L468A and I477A was not due to misfolding or indirect effects
on calcium binding (in contrast to a previously studied D469G
substitution) because two-dimensional NOESY analysis
showed that a marker for calcium binding to EGF12 (Tyr-444)
gave a similar change in chemical shift upon the addition of
Ca2 to that observed in the WT (Fig. 2b) (14). The crystal
structure of hN-111–13 (PDB 2VJ3) has previously shown that
Leu-468 and Ile-477 side chains form a hydrophobic interac-
tion across the central-hairpin of EGF12 (19); our data suggest
that this structural feature may serve as a stable platform for
ligand interactions (Fig. 2c).
Site-directed Mutagenesis of Full-length Drosophila Notch—
To extend this analysis to full-length Notch, we then substi-
tuted the equivalent amino acids in the evolutionarily distant
dN and tested these mutants for interaction with Drosophila
Serrate using cell aggregation assays. Results were very sim-
ilar to those seen with the hN-111–13/J-1 interaction, with dN
L504A showing the strongest reduction of binding, and as
expected, a concomitant reduction in ligand-induced signal-
ing (Fig. 3). An exception was dN V513A, which reduced but
did not abrogate binding as had the equivalent hN-111–13
I477A. This most likely reflects themore conservative nature
of a valine to alanine change than that of the more bulky
isoleucine to alanine. Collectively, our data suggest that the
location of the ligand-binding site for the Jagged/Serrate
family ligands is conserved across human and Drosophila
Notch (Table 1) despite the observed sequence divergence
within this region (Fig. 1b).
FIGURE 1.Defining the J-1-binding site in hN-1. a, domain organization of hN-1 showing structure of the hN-111–13 ligand-binding region (ProteinData Bank
(PDB) 2VJ3). LNR, Lin12-Notch Repeat modules; HD, Heterodimerization Domain; NICD, Notch Intracellular Domain. Red spheres indicate calcium ions.
b, sequence homology of Notch EGF12 region fromdifferent species and the four human paralogues; cysteines are shown in black, calcium-binding consensus
residues are in gray, two universally conserved residues that are candidates for ligand binding are boxed, and additional residues within the EGF12 -hairpin
targeted for mutagenesis are indicated by a red asterisk. D. melanogaster, Drosophila melanogaster.
Jagged-1/Serrate Recognition by Notch
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These mutational data now implicate a different face of
Notch in ligand binding from our earlier studies based onNMR
data derived from mapping intensity changes in the spectrum
of hN-111–13 upon titration of an hJ-1DSL-EGF3 fragment (19)
(the more informative chemical shift mapping was not possible
due to a combination of the poor solubility of hJ-1DSL-EGF3 and
the kinetics/affinity of the interaction). The most perturbed
residues in this assay were hN-1 Val-453 and Gly-472, which
contribute to the EGF12 calcium binding by donation of a back-
bone carbonyl ligand and to an EGF11–12 packing interaction,
respectively. The spatial distance and orientation of Val-453
and Gly-472, when compared with the Leu-468 and Ile-477
hydrophobic patch identified as being important for ligand
binding in this study, preclude both sites making direct con-
tacts to the ligand. To try and resolve this contradiction, we
mutated the Val-453 equivalent residue, Ile-489, in dN. This
had no effect on ligand binding (data not shown), implying that
the intensity changes observed previously (19) reflect an indi-
rect effect on the residues stabilizing calcium binding to EGF12
by ligand binding within the central -hairpin (because -hair-
pin stability and calcium binding affinity are closely coupled).
This conservation of ligand-binding site between human and
evolutionary distant DrosophilaNotch proteins, despite a rela-
tively high level of sequence diversity (Fig. 1b) anddifferences in
the specific ligands assayed, suggests that this region of Notch
will be involved in ligand binding in all species. It is also
interesting to note that the threonine/serine residue (Thr-
466 in hN-111–13/Ser-502 in dN), implicated in the regula-
FIGURE 2. Characterization and interaction studies of hN-1 variants. a, flow cytometry analysis of the interaction between J-1 and biotinylated wild-type
(WT) and mutant N-111–13 constructs. Left-hand panel, flow cytometry of B16 cells expressing J-1 after interaction with biotinylated hN-1 mutants(red line)
bound to avidin-coated fluorescent beads (see “Experimental Procedures”); in each case, a negative control (fibrillin calcium-binding EGF12–14, gray shading)
and positive control (WT hN-111–13, black line) are shown. Three representative mutant constructs are shown; M479A is indistinguishable from WT, L468A
overlays negative control, and Q475A shows intermediate binding. Right-hand panel, quantification of flow cytometry data for all EGF12 mutants expressed
relative to WT control (WT 1) (bars indicate mean, error bars indicate S.D., n 3) andWestern blot of hN-111–13 samples to show experiments controlled for
protein loading. b, NMR analysis shows that WT and mutant constructs have native-like calcium binding properties indicative of correct folding. Aromatic
regions of 1H-1H two-dimensional NOESY spectra at pH 7.5 of hN-111–13 WT, L468A, and I477A are shown. A marker for calcium binding in EGF12 (Tyr-444) is
highlighted in the absence (blue) and presence (red) of Ca2 (15mM), and the shift is indicated by a red arrow. Quantification of data indicates relative chemical
shift change on addition of Ca2. Red, WT; blue, L468A; green, I477A. The structure of hN-1 EGF12 (PDB 2VJ3) is shown; residues implicated in binding by flow
cytometry (red), non-binding residues (blue), position of residue Thr-466 that is implicated in regulation byO-fucosylation, and Fringe extension are indicated.
Jagged-1/Serrate Recognition by Notch
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tion of Notch activity by O-fucosylation and subsequent
Fringe extension, lies adjacent to the ligand-binding patch
revealed in EGF12 (Fig. 2c), suggesting that direct effects on
ligand recognition may explain the functional effects of this
modification (25, 26).
Sequence Variation in Notch Paralogues—Inspection of the
amino acid sequences of residues in the vicinity of our newly
defined Notch ligand-binding site across mammalian Notch
paralogues (human Notch 1–4 shown) reveals sequence varia-
tion (Fig. 1b), as we have observed between hN-1 andDrosoph-
ila Notch. Our binding data for human N-1 show that alanine
substitution of residues in close proximity to the core binding
site can subtly enhance or reduce ligand binding (Fig. 2a). One
explanation for the sequence variation seen in such a function-
ally important site therefore is to allow fine tuning of the affin-
ity, specificity, and regulation of different Notch-ligand combi-
nations (there are five ligands and four Notch receptors in
mammals). This is consistent with data from various assays that
have demonstrated that hNotch paralogues 1–3 can all interact
with both J-1 and Dll-1 (7, 14, 27–29). All paralogues maintain
the leucine-isoleucine, or leucine-leucine, pairings predicted
on the basis of structural homology with hN-1 to form the
ligand-binding platform. It is also interesting to note thatXeno-
pus Notch (Xotch) (which has an identical -hairpin sequence
between C3 and C5 in EGF12 to hN-1 (Fig. 1b)) has been
observed to bind toDrosophila ligands Serrate and Delta (6). A
potential consequence of the observed variability in the binding
site is to allow generation of paralogue-specific antibodies that
block ligand binding.
Production of Paralogue-specific Antibodies—To test our
hypothesis, we have used our soluble hN-111–13 containing the
ligand-binding site to generate a panel of mAbs. Of these, one
mAb (N1-39E) is seen to block receptor/ligand complex forma-
tion between hN-111–13 and cell surface expressed J-1 in our
flow cytometry assay, whereas another mAb N1-96A has no
effect on the interaction (Fig. 4a). Epitope mapping localizes
the binding site of both N1-39E and N1-96A to EGF12 and/or
the C-terminal region of EGF11 because they both recognize
hN-1 mutants defective in calcium binding to EGF11 and
EGF13, but do not recognize a mutant defective in calcium
binding to EGF12 (Fig. 4b). Subsequent testing against our panel
of hN-1 EGF12 mutants demonstrates that the epitope of
N1-39E, but not N1-96A, encompasses residues 468–477 of
hN-1, which includes Leu-468 and Ile-477, directly implicated
above in ligand binding, and Gln-470, Glu-473, and Gln-475
(Fig. 4c). The N1-39E epitope thus lies within the EGF12 Notch
ligand-recognition site, explaining the molecular mechanism
underlying its blockade of the hN-1/J-1 interaction. To test
whether or not N1-39E is paralogue-specific, as suggested by
the residues that form its epitope (Figs. 1b and 4c), we assayed
whether or not it could recognize HEK 293 cells transfected
individually with the different hNotch paralogues (N-1, N-2,
N-3, and N-4). Flow cytometry analysis demonstrated that
N1-39E specifically recognized only HEK293 cells expressing
N-1 (expression of hNotch by each transfected cell line was
confirmed by immunocytochemistry (Fig. 4d)). Recent work
has demonstrated that selective interference of Notch paral-
ogue activity by antibody binding can inhibit tumor growth in
mouse xenograft models with reduced intestinal toxicity (30).
Such reagents are likely to be valuable in the treatment of
FIGURE 3. Defining the ligand-binding site in dN. a–c, cell aggregation
assay of the interaction of full-length Serrate with WT and alanine substitu-
tion mutants of full-length dN expressed in S2 cells. Panels show merged
immunofluorescence images of Serrate (purple), Notch (green), and DAPI
(blue). Aggregated cells form junctionswith clustered Serrate andNotch indi-
cated by arrows, which are clearly evident for WT Notch (a) and the M515A
mutant (b) but not for the L504A construct (c). The latter is shown at lower
magnification to depict a field of nonaggregating cells. Scale bars are: 5m(a
and b) and 10 m (c). d, cell aggregation assay scored as the percentage of
Notch-expressing cells adhered to at least one Serrate-expressing cell for WT
dN, the control D505A substitution, and for substitutions located around the
main -sheet of EGF12. Error bars in d indicate S.D., n 3. e, Notch luciferase-
reporter signaling assay. Mean normalized Notch signaling is shown relative
to WT Notch expressed in S2 cells co-cultured with nonexpressing S2 cells.
Signaling through wild-type Notch is increased by ligand-expressing (Delta)
co-cultured S2 cells, but signaling through L504A mutant is not changed by
exposure to ligand. EV, empty vector-transfected luciferase reporter controls.
Error bars in e indicate S.D., n 6.
TABLE 1
Site-directed mutagenesis of residues in hN-1 and Drosophila Notch and their respective effects in flow cytometry, ligand binding, and cell
aggregation assays
ND, not determined.
hN-1 residue
and substitution
EGF
domain
Effect on ligand binding observed
in flow cytometry analysis
Equivalent substitution in
DrosophilaNotch
Effect on Notch/Serrate
cell aggregation
Q442Aa 11 Binds as WT Q478A Close to WT level
L468A 12 No binding L504A Strongly reduced
D469Gb 12 No binding D505A Strongly reduced
Q470A 12 Binds as WT ND ND
E473A 12 Moderate binding T509A Moderately reduced
Q475A 12 Moderate binding R511A Moderately reduced
I477A 12 No binding V513A Moderately reduced
M479A 12 Binds as WT M515A Binds as WT
a Gln-442 in EGF11 is in close proximity to the region of ligand binding in EGF12.
b Conserved calcium-binding residue. Loss of ligand binding is due to loss in structural integrity, rather than direct involvement in N-1/ligand interaction.
Jagged-1/Serrate Recognition by Notch
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breast, melanoma, and T-cell acute lymphoblastic leukemia
cancers, which are associated with aberrant Notch signaling, as
well as important research tools (31). To date, potential thera-
peutic antibodies have targeted the negative regulatory region
of Notch and have shown activity against Notch-1, -2, and -3
(30, 32, 33); antibodies to the extracellular domain of hN-1
encompassing EGF1–13 and EGF11–15 have also been reported
(33, 34). We have now demonstrated a strategy for producing
paralogue-specific antibodies to a region known to be critical
for ligand binding. It should be noted thatmonoclonal antibod-
ies raised to the ligand-binding region of Notch, and which
block binding, may or may not reduce signaling (34, 35). This is
FIGURE 4. Characterization of a ligand-blockingmAb to hN-1, which recognizes J-1-binding site. a, flow cytometry assay to showmAb N1-39E (red), but
not N1-96A (blue), blocks the binding of hN-111–13 to HEK cells expressing hJ-1. b and c, epitopemapping by dot-blotting ofWT andmutant hN-111–14 proteins
(11NG, 12DG, 13DG) that contain a calcium-binding mutation in EGF11, EGF12, or EGF13 localizes the epitope of mAb N1-39E and N1-96A to EGF12 or the C
terminus of EGF11. Dot-blotting of a panel of hN-1 EGF12 mutants demonstrates that L468A, Q470A, E473A, Q475A, and I477A are not recognized by N1-39E,
and thus formpart of its epitope. d, flow cytometry and immunocytochemistry (cytospin) analysis demonstrates that N1-39E is paralogue-specific. The red line
indicates binding of mAb N1-39E; only 293T cells expressing hN-1 show a positive result, indicated by a rightward shift. Cytospin analysis (using monoclonal
(mAb) or polyclonal (pAb) paralogue-specific antibodies) shows that each transfected cell line tested expresses a specific human Notch paralogue.
FIGURE 5.Amino acid residueswithin-hairpin implicated in ligand recognition and antibody binding in human andDrosophilaNotch. EGF12 of hN-1
is shown as a graphic and overlaid with a semitransparent surface. Positions that perturb activity in an assay are colored in red, those with no effect are colored
in blue, and those not probed are colored in gray.
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most likely due to the different affinities of the antibodies, their
ability to recognize post-translationally modified forms of the
receptor, or the cells used in the signaling assay expressing
more than one paralogue on the cell surface. Nevertheless,
given appropriate scale-up and screening of the molecular
properties of such antibodies, this approach should yield
reagents important for future research and therapeutics.
Our data demonstrate that the position and hydrophobic
nature of the binding site for Jagged/Serrate ligands is con-
served on the Notch EGF12 molecular surface throughout evo-
lution (Fig. 5). Despite such global conservation, individual
differences within the EGF12 site occur, suggesting that fine-
tuning of the receptor/ligand interaction is possible, whichmay
be subject to further regulation byO-glycosylation. As a conse-
quence of the sequence variation observed, we demonstrate
that it is possible to make targeted paralogue-specific, ligand-
blocking mAbs (Fig. 5), which may be important for future
research and therapeutics.
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